Literature DB >> 2165452

Mortality in patients with familial adenomatous polyposis.

M L Arvanitis1, D G Jagelman, V W Fazio, I C Lavery, E McGannon.   

Abstract

The authors identified 132 patients who died with a documented diagnosis of familial adenomatous polyposis (FAP). A review of the medical records, autopsy reports, and in-depth discussion with local physicians and well-informed family members was performed. It was impossible, even after the review, to ascertain the exact cause of death in 22 patients. In the remaining patients, the cause of death was as follows: metastatic colorectal carcinoma, 64 patients (58.2 percent), (colon, 49 [44.5 percent], rectal, 15 [13.6 percent]); desmoid tumors, 12 (10.9 percent); periampullary carcinoma, 9 (8.2 percent); brain tumors, 8 (7.3 percent); perioperative mortalities, 5 (4.5 percent); adrenal carcinoma, 1 (0.9 percent); and abdominal carcinomatosis, 1 (0.9 percent). Ten patients died of causes not related to FAP. The major causes of death in 36 patients who underwent prophylactic colectomy were desmoid tumor and periampullary malignancy. This finding underscores the importance of lifelong surveillance and periodic endoscopic evaluation in patients with FAP.

Entities:  

Mesh:

Year:  1990        PMID: 2165452     DOI: 10.1007/BF02150736

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  81 in total

1.  FAP, gastric cancer, and genetic counseling featuring children and young adults: a family study and review.

Authors:  Henry T Lynch; Carrie Snyder; Janine M Davies; Stephen Lanspa; Jane Lynch; Zoran Gatalica; Victoria Graeve; Jason Foster
Journal:  Fam Cancer       Date:  2010-12       Impact factor: 2.375

Review 2.  Lower gastrointestinal tract cancer predisposition syndromes.

Authors:  Neel B Shah; Noralane M Lindor
Journal:  Hematol Oncol Clin North Am       Date:  2010-12       Impact factor: 3.722

Review 3.  Familial adenomatous polyposis: a case report and review of the literature.

Authors:  D Beech; A Pontius; N Muni; W P Long
Journal:  J Natl Med Assoc       Date:  2001-06       Impact factor: 1.798

4.  Adenoma of the common human bile duct in Gardner's syndrome may cause relapsing acute pancreatitis.

Authors:  H Futami; T Furuta; H Hanai; S Nakamura; S Baba; E Kaneko
Journal:  J Gastroenterol       Date:  1997-08       Impact factor: 7.527

5.  Villous tumors of the duodenum: reappraisal of local vs. extended resection.

Authors:  M B Farnell; G H Sakorafas; M G Sarr; C M Rowland; G G Tsiotos; D R Farley; D M Nagorney
Journal:  J Gastrointest Surg       Date:  2000 Jan-Feb       Impact factor: 3.452

Review 6.  [Preventive surgery for familial adenomatous polyposis coli].

Authors:  M Kadmon
Journal:  Chirurg       Date:  2005-12       Impact factor: 0.955

7.  Duodenal cancer arising from the remaining duodenum after pylorus-preserving pancreatoduodenectomy for ampullary cancer in familial adenomatous polyposis.

Authors:  Yoshiaki Murakami; Kenichiro Uemura; Masaru Sasaki; Masahiko Morifuji; Yasuo Hayashidani; Takeshi Sudo; Taijiro Sueda
Journal:  J Gastrointest Surg       Date:  2005-03       Impact factor: 3.452

8.  Primary duodenal carcinoma.

Authors:  O A Adedeji; C Trescoli-Serrano; M Garcia-Zarco
Journal:  Postgrad Med J       Date:  1995-06       Impact factor: 2.401

9.  Endoscopic snare papillectomy with biliary and pancreatic stent placement for tumors of the major duodenal papilla.

Authors:  Takuji Yamao; Hajime Isomoto; Shigeru Kohno; Yohei Mizuta; Masaki Yamakawa; Kazuhiko Nakao; Junji Irie
Journal:  Surg Endosc       Date:  2009-06-11       Impact factor: 4.584

10.  APC mutation spectrum of Norwegian familial adenomatous polyposis families: high ratio of novel mutations.

Authors:  Per Arne Andresen; Ketil Heimdal; Kristin Aaberg; Katrine Eklo; Kristin Eklo; Sarah Ariansen; Alexandra Silye; Olav Fausa; Lars Aabakken; Stefan Aretz; Tor J Eide; Tobias Gedde-Dahl
Journal:  J Cancer Res Clin Oncol       Date:  2009-05-15       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.